Abrdn Healthcare Investors Past Earnings Performance
Past criteria checks 1/6
Abrdn Healthcare Investors's earnings have been declining at an average annual rate of -10%, while the Capital Markets industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 4.8% per year. Abrdn Healthcare Investors's return on equity is 6%, and it has net margins of 547.4%.
Key information
-10.0%
Earnings growth rate
-9.9%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | 4.8% |
| Return on equity | 6.0% |
| Net Margin | 547.4% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
HQH: Healthcare Fund With 11% Income And A High Discount
Mar 03HQH: Disappointing Track Record
Feb 04HQH: I Am Getting A 9.5% Yield On My Last Buy
Dec 19HQH: New Name But Same Risky Bets On Biotech
Nov 14HQH: Deep Discount Presents An Opportunity
Jul 03Tekla Healthcare Investors raises dividend by 7.7% to $0.42
Feb 15HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering
Dec 24Equity CEFs: What's Going On With Tekla's HQH And HQL?
Dec 08Tekla Healthcare Investors declines quarterly dividend by -2.5% to $0.39/share
Nov 16HQH: A Dividend Paymaster That Fails To Register Price Growth
Oct 20Tekla Healthcare Investors goes ex-dividend tomorrow
Aug 24Tekla Healthcare: 10% Yielding CEF Trading Below NAV
Jul 17Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Mar 30Tekla Healthcare Investors: Understanding The Mechanics Of Its 8.5% Yield
Jan 16Technical Update On HQH: Presenting An Opportunity
Oct 06HQH: Higher Valuation, But Still Appealing
Jul 31Where Fundamentals Meet Technicals: HQH (Revisited) - Yield 7.74%
Jul 08Evaluating CEFs: HQH Provides A Well-Covered Distribution In A Hot Sector
Jun 27HQH: An Overweight Biotech Fund, Paying 8%+ Distribution
Jan 14Tekla Healthcare Investors declares $0.05 special dividend
Dec 21Tekla Healthcare Investors declares $0.48 dividend
Nov 16HQH: Deep Discount Leads To High Yield
Nov 09Revenue & Expenses BreakdownBeta
How Abrdn Healthcare Investors makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 10 | 56 | 11 | 0 |
| 30 Jun 23 | 10 | 30 | 12 | 0 |
| 31 Mar 23 | 10 | 4 | 12 | 0 |
| 31 Dec 22 | 9 | -95 | 12 | 0 |
| 30 Sep 22 | 8 | -194 | 12 | 0 |
| 30 Jun 22 | 8 | -121 | 12 | 0 |
| 31 Mar 22 | 7 | -48 | 13 | 0 |
| 31 Dec 21 | 7 | 53 | 13 | 0 |
| 30 Sep 21 | 6 | 155 | 13 | 0 |
| 30 Jun 21 | 7 | 218 | 12 | 0 |
| 31 Mar 21 | 7 | 282 | 12 | 0 |
| 31 Dec 20 | 8 | 261 | 11 | 0 |
| 30 Sep 20 | 9 | 241 | 11 | 0 |
| 30 Jun 20 | 9 | 114 | 11 | 0 |
| 31 Mar 20 | 9 | -13 | 10 | 0 |
| 31 Dec 19 | 8 | -79 | 10 | 0 |
| 30 Sep 19 | 8 | -145 | 10 | 0 |
| 30 Jun 19 | 8 | -47 | 11 | 0 |
| 31 Mar 19 | 7 | 50 | 11 | 0 |
| 31 Dec 18 | 7 | 60 | 11 | 0 |
| 30 Sep 18 | 7 | 69 | 11 | 0 |
| 30 Jun 18 | 6 | 45 | 11 | 0 |
| 31 Mar 18 | 6 | 20 | 11 | 0 |
| 31 Dec 17 | 6 | 71 | 11 | 0 |
| 30 Sep 17 | 6 | 121 | 11 | 0 |
| 30 Jun 17 | 5 | 110 | 11 | 0 |
| 31 Mar 17 | 5 | 98 | 10 | 0 |
| 31 Dec 16 | 5 | 21 | 11 | 0 |
| 30 Sep 16 | 5 | -56 | 11 | 0 |
| 30 Jun 16 | 5 | -142 | 12 | 0 |
| 31 Mar 16 | 5 | -227 | 12 | 0 |
| 31 Dec 15 | 5 | -66 | 12 | 0 |
| 30 Sep 15 | 4 | 96 | 12 | 0 |
| 30 Jun 15 | 4 | 215 | 11 | 0 |
| 31 Mar 15 | 3 | 334 | 11 | 0 |
| 31 Dec 14 | 2 | 278 | 10 | 0 |
| 30 Sep 14 | 2 | 222 | 9 | 0 |
| 30 Jun 14 | 2 | 224 | 9 | 0 |
| 31 Mar 14 | 2 | 227 | 8 | 0 |
| 31 Dec 13 | 2 | 214 | 8 | 0 |
| 30 Sep 13 | 2 | 200 | 7 | 0 |
| 30 Jun 13 | 3 | 161 | 7 | 0 |
Quality Earnings: HQH has a large one-off gain of $57.5M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: HQH became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HQH's earnings have declined by 10% per year over the past 5 years.
Accelerating Growth: HQH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HQH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (3.3%).
Return on Equity
High ROE: HQH's Return on Equity (6%) is considered low.